Metraipolis › archive › dc_a002e5c6cfba

Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy — Europe PMC PMID:41907623

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41907623
DOI
10.3389/fonc.2026.1738551
License (as archived)
solo-consultazione
Archived
2026-11-04T11:34:53.528Z
SHA-256 of the archived text
08c876664893d11dad48b8e278544207083c87f37b3aceb0b4e71534fbdc2224
Stable URL of this page
https://metraipolis.com/documento/dc_a002e5c6cfba

How to cite

Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy — Europe PMC PMID:41907623 — Europe PMC (en), https://europepmc.org/article/MED/41907623 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a002e5c6cfba (Metraipolis archive dc_a002e5c6cfba, sha256 08c876664893d11dad48b8e278544207083c87f37b3aceb0b4e71534fbdc2224)
BibTeX
@misc{dca002e5c6cfba,
  title = {Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy — Europe PMC PMID:41907623},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41907623},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a002e5c6cfba; sha256 08c876664893d11dad48b8e278544207083c87f37b3aceb0b4e71534fbdc2224},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41907623. Agents can read the archived copy with the MCP tool read_document.